Abstract
BackgroundThe response of solid tumors such as papillary thyroid cancer (PTC) to immune checkpoint inhibitors (ICIs) is highly variable. The biological basis of this variability remains unknown.MethodsTo test the hypothesis...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have